The emerging therapy of this peptide represents a exciting breakthrough in the management of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and the GIP hormone – leading https://tirzepatide-peptide186358.ivasdesign.com/63182053/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment